Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: Findings from the National Surgical Adjuvant Breast and Bowel Project

Journal of the National Cancer Institute

Volumn 91, Issue 22, 1999, Pages 1933-1940

  Dignam, James J ^a   Colangelo, Linda ^a   Tian, Wei ^a   Jones, Judy ^a   Smith, Roy ^b   Wickerham, D Lawrence ^b   Wolmark, Norman ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COLON CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL;

EID: 0033579135     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/91.22.1933     Document Type: Article

References (43)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin 1999;49:8-31, 1.
2. Dayal H, Polissar L, Yang CY, Dahlberg S. Race, socioeconomic status, and other prognostic factors for survival from colo-rectal cancer. J Chronic Dis 1987;40:857-64.
3. Godwin JD 2d, Brown CC. Some prognostic factors in survival of patients with cancer of the colon and rectum. J Chronic Dis 1975;28:441-54.
4. Koch M, McPherson TA, Egedahl RD. Effect of sex and reproductive history on the survival of patients with colorectal cancer. J Chronic Dis 1982;35:69-72.
5. Krain LS. Racial and socioeconomic factors in colonic cancer survival. Ann Surg 1972;175:601-6.
6. Ries LA, Kosary CL, Hankey BF, Miller BA, Edwards BK, editors. SEER cancer statistics review, 1973-1995. Bethesda (MD): National Cancer Institute; 1998.
7. Axtell LM, Myers MH. Contrasts in survival of black and white cancer patients, 1960-73. J Natl Cancer Inst 1978;60:1209-15.
8. Bean RW, Steele GD Jr, Menck HR, Chmiel JS. Ocwieja KE, Winchester DP. Management and survival of patients with adenocarcinoma of the colon and rectum: a national survey of the Commission on Cancer. J Am Coll Surg 1995;181:225-36.
9. Miller BA, Kolonel LN, Bernstein L. Young JL Jr, Swanson GM, West D, et al, editors. Racial/ethnic patterns of cancer in the United States 1988-1992. Bethesda (MD): National Institutes of Health, National Cancer Institute; 1996 Report No.: DHHS Publ No. (NIH)96-4104.
10. Young JL Jr, Ries LG, Pollack ES. Cancer patient survival among ethnic groups in the United States. J Natl Cancer Inst 1984;73:341-52.
11. th ed. Philadelphia (PA): Lippincott; 1992.
12. Wolmark N, Fisher B, Rockette H, Redmond C, Wickerham DL, Fisher ER, et al. Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01. J Natl Cancer Inst 1988;80:30-6.
13. Wolmark N, Rockette H, Wickerham DL, Fisher B, Redmond C, Fisher ER, et al. Adjuvant therapy of Dukes' A, B, and C adenocarcinoma of the colon with portal-vein fluorouracil hepatic infusion: preliminary results of National Surgical Adjuvant Breast and Bowel Project protocol C-02. J Clin Oncol 1990;8:1466-75.
14. Wolmark N, Rockette H, Fisher B, Wickerham DL, Redmond C, Fisher ER, et al. The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. J Clin Oncol 1993;11:1879-87.
15. Wolmark N, Rockette H, Mamounas E, Jones J, Wieand S, Wickerham L, et al. Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project C-04. J Clin Oncol. In press 1999.
16. Wolmark N. Bryant J, Smith R, Grem J. Allegra C, Hyams D, et al. Adjuvant 5-fluorouracil and leucovorin with or without interferon alfa-2a in colon carcinoma: National Surgical Adjuvant Breast and Bowel Project protocol C-05. J Natl Cancer Inst 1998;90:1810-6.
17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
18. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-70.
19. Cox DR. Regression models and life tables. J R Stat Soc 1972;34:187-220.
20. Prentice RL, Kalbfleisch JD, Peterson AV Jr, Flournoy N, Farewell VT, Breslow NE. The analysis of failure times in the presence of competing risks. Biometrics 1978;34:541-54.
21. Elandt-Johnson RC, Johnson NL. Survival models and data analysis. New York (NY): John Wiley & Sons; 1980.
22. Ball JK, Elixhauser A. Treatment differences between blacks and whites with colorectal cancer. Med Care 1996;34:970-84.
23. Cooper GS. Yuan Z, Landefeld CS. Rimm AA. Surgery for colorectal cancer: race-related differences in rates and survival among Medicare beneficiaries. Am J Public Health 1996;86:582-6.
24. Page WF, Kuntz AJ. Racial and socioeconomic factors in cancer survival. A comparison of Veterans Administration results with selected studies. Cancer 1980;45:1029-40.
25. Dominitz JA, Samsa GP, Landsman P, Provenzale D. Race, treatment, and survival among colorectal carcinoma patients in an equal-access medical system. Cancer 1998;82:2312-20.
26. Keim W, Metter G. Survival of cancer patients by economic status in a free care setting. Cancer 1985;55:1552-5.
27. Chen VW, Fenoglio-Preiser CM, Wu XC, Coates RJ, Reynolds P, Wickerham DL, et al. Aggressiveness of colon carcinoma in blacks and whites. National Cancer Institute Black/White Cancer Survival Study Group. Cancer Epidemiol Biomarkers Prev 1997;6:1087-93.
28. Chen VW, Correa P, Kurman RJ, Wu XC, Eley JW, Austin D, et al. Histological characteristics of breast carcinoma in blacks and whites. Cancer Epidemiol Biomarkers Prev 1994;3:127-35.
29. Nelson RL, Dollear T, Freels S, Persky V, The relation of age, race, and gender to the subsite location of colorectal carcinoma. Cancer 1997;80: 193-7.
30. Johnson H Jr, Carstens R. Anatomical distribution of colonic carcinomas. Interracial differences in a community hospital population. Cancer 1986; 58:997-1000.
31. Yancik R. Wesley MN, Ries LA, Havlik RJ, Long S, Edwards BK, et al. Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study. Cancer 1998; 82:2123-34.
32. Remington RD. Who should code cause of death in a clinical trial? Controlled Clin Trials 1984;5:241-4.
33. Messite J, Stellman SD. Accuracy of death certificate completion: the need for formalized physician training. JAMA 1996;275:794-6.
34. McWhorter WP, Mayer WJ. Black/white differences in type of initial breast cancer treatment and implications for survival. Am J Public Health 1987;77:1515-7.
35. Diehr P, Yergan J, Chu J, Feigl P, Glaefke G, Moe R, et al. Treatment modality and quality differences for black and white breast-cancer patients treated in community hospitals. Med Care 1989;27:942-58.
36. Whittle J, Conigliaio J, Good CB, Lofgren RP. Racial differences in the use of invasive cardiovascular procedures in the Department of Veterans Affairs medical system. N Engl J Med 1993;329:621-7.
37. Mandelblatt J, Andrews H, Kao R, Wallace R, Kerner J. The late-stage diagnosis of colorectal cancer: demographic and socioeconomic factors. Am J Public Health 1996;86:1794-7.
38. Liff JM, Chow WH, Greenberg RS. Rural-urban differences in stage at diagnosis. Possible relationship to cancer screening. Cancer 1991;67: 1454-9.
39. Weaver P, Harrison B, Eskander G, Jahan MS, Tanzo V, Williams W, et al. Colon cancer in blacks: a disease with a worsening prognosis. J Natl Med Assoc 1991;83:133-6.
40. Tejeda HA, Green SB, Trimble EL, Ford L, High JL, Ungerleider RS, et al. Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials. J Natl Cancer Inst 1996;88:812-6.
41. Watanabe ME. "Amid criticism, NCI tries to boost minority clinical-trial recruitment." The Scientist 1996;10:7 p. 1, 4-5, April 1.
42. Brown KS. "Scientists, African-American clergy join forces for trial recruitment." The Scientist 1997;11:4 p. 1, 10, February 17.
43. Macdonald JS. Adjuvant therapy for colon cancer. CA Cancer J Clin 1997; 47:243-56.